Chemical and Pharmaceutical Bulletin · 2001 · 30 citations · 17 references
MedicineMedicinal ChemistryPharmacologyAntimicrobial PharmacologyChemotherapyDrug DiscoveryAntiparasitic AgentsAntiparasitic ChemotherapyAntiparasitic Drug ResistanceAntiparasitic PharmacologyAntiparasitic TherapyMalariaAntimalarial AgentsAntimalarial ChemotherapyAntimalarial Drug DevelopmentChemotherapy Of MalariaIn Vivo StudiesPeritoneal MacrophagesPlasmodium FalciparumTreatment Of Malaria
Amodiaquine (AQ) is an antimalarial which is effective against chloroquino-resistant strains of Plasmodium falciparum but whose clinical use is severely restricted because of associated hepatotoxicity and agranulocytosis. "One-pot" synthesis of formamidines likely to be transformed into AQ derivatives is reported. Compared with AQ, the new compounds were devoid of in vitro cytotoxicity upon human embryonic lung cells and mouse peritoneal macrophages. One showed a potent in vivo activity in mice infected with P berghei. Transformation of this compound by reductive amination led to a new type of AQ derivatives that displayed an in vitro activity similar to that of AQ but did not lead to toxic quinone-imines.
17
Human Malaria Parasites in Continuous Culture
William Trager, James B. Jensen · Science · 1976 · 8K citations
Ahmed F. Abdel‐Magid, Kenneth G. Carson, Bruce D. Harris et al. · The Journal of Organic Chemistry · 1996 · 1.5K citations
Amodiaquine induced agranulocytosis and liver damage.
K Neftel, W Woodtly, M. Schmid et al. · BMJ · 1986 · 292 citations · Full text
Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12